We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

SUBSCRIBE: Print / eNewsletter

HIV Postexposure Prophylaxis Guidelines

Jan 1, 2002
Volume: 
11
Issue: 
1

ATLANTA—Health care personnel exposed to HIV should be
evaluated within hours (rather than days) after their exposure and should be
tested for HIV at baseline (ie, to establish infection status at the time of
exposure), according to the latest HIV postexposure prophylaxis (PEP)
guidelines from the US Public Health Service [MMWR 50:(RR11):1-42, 2001].

Because most occupational HIV exposures do not result in the
transmission of HIV, potential toxicity must be carefully considered when
prescribing PEP (see Table). Health care personnel with occupational exposure
to HIV should receive follow-up counseling, postexposure testing, and medical
evaluation, regardless of whether they receive PEP. For management resources,
see PEPline (www.ucsf.edu/hivcntr) and Needlestick! (www.needlestick.mednet.ucla.edu).

The basic 2-drug PEP regimens, given for 4 weeks, as
recommended in the Table, are zidovudine (Retrovir)/lamivudine (Epivir)
(available as Combivir); lamivudine/stavudine (Zerit); and didanosine
(Videx)/stavudine.

The expanded 3-drug regimen consists of a basic regimen plus
indinavir (Crixivan), nelfinavir (Viracept), efavirenz (Sustiva), or abacavir
(Ziagen). Abacavir is available in combination with zidovudine and lamivudine
as Trizivir.

Drugs for use as PEP with expert consultation include ritonavir
(Norvir), saquinavir (Fortovase), amprenavir (Agenerase), delavirdine
(Rescriptor), and lopinavir/ritonavir (Kaletra). 

Resource Topics rightRail

  • Resource Topics
  • Partner Content
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Melanoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

Oncology Vol 32 No 4
Apr 15, 2018 Vol 32 No 4
Digital Edition
Subscribe
Connect with Us
  • Twitter
  • Facebook
  • LinkedIn
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.